This article was accepted into the corpus but its outbound wikilinks were never NER-processed — typical at the deepest BFS hop or when the run's entity cap was reached. No expansion funnel to show.
| Sudden Death in the Young (SDY) Case Registry | |
|---|---|
| Name | Sudden Death in the Young (SDY) Case Registry |
| Formation | 2010s |
| Type | Public health surveillance registry |
| Headquarters | United States |
| Parent organization | Centers for Disease Control and Prevention |
Sudden Death in the Young (SDY) Case Registry is a national surveillance initiative designed to collect, analyze, and interpret data on unexplained sudden deaths among infants, children, adolescents, and young adults. The registry connects multidisciplinary stakeholders to improve case investigation, promote standardized autopsy and molecular testing, and inform prevention strategies. It operates at the intersection of forensic pathology, pediatric cardiology, genetics, and public health surveillance.
The registry aggregates case-level information from medical examiners, coroners, hospitals, and laboratories to study unexplained fatalities among young people, linking clinical, pathological, and molecular data to identify causes and risk factors. Participating contributors include institutions such as the Centers for Disease Control and Prevention, National Institutes of Health, American Academy of Pediatrics, and state-level public health departments, while professional collaborators span College of American Pathologists, American Heart Association, and academic centers like Johns Hopkins University, Harvard University, Stanford University, and University of California, San Francisco. The dataset supports epidemiological analyses, case-series reports, and translational research involving specialists from Mayo Clinic, Cleveland Clinic, Massachusetts General Hospital, and other referral centers.
The registry was established in response to accumulating evidence from surveillance, case reports, and consensus conferences about unexplained sudden deaths among the young in the early 21st century. Influential events and organizations informing its creation included policy dialogues at the Centers for Disease Control and Prevention, funding and methodological frameworks from the National Institutes of Health, and technical guidance from the National Association of Medical Examiners and Council of State and Territorial Epidemiologists. Pilot programs were launched in collaboration with academic partners such as Columbia University, University of Pennsylvania, and Yale University and with engagement from advocacy groups including March of Dimes and American Foundation for Suicide Prevention.
Primary objectives include standardizing case investigation protocols, improving identification of genetic and acquired causes, and enabling prevention through data-driven recommendations. The scope covers sudden unexplained infant deaths, sudden unexpected pediatric deaths, and sudden cardiac death in adolescents and young adults, intersecting clinical domains represented by the American College of Cardiology, European Society of Cardiology, and subspecialties at centers like Boston Children's Hospital and Seattle Children's Hospital. Secondary aims include capacity building for medicolegal death investigation systems in jurisdictions across the United States, collaboration with international partners such as Public Health England, World Health Organization, and research dissemination through journals like The New England Journal of Medicine and Journal of the American Medical Association.
Cases are typically identified through notifications from medical examiners, coroners, emergency departments at hospitals like Rady Children's Hospital, and death certification systems managed by state vital records offices. Inclusion criteria prioritize age (infants through young adults), suddenness of death, lack of an immediately apparent cause after scene investigation, and the absence of significant preexisting terminal conditions; these criteria were developed with input from panels convened by CDC and experts from American Academy of Forensic Sciences, Pediatric Academic Societies, and clinical genetics programs at institutions such as University of Michigan and University of Washington. Standardized case definitions align with recommendations from consensus conferences involving representatives of American Academy of Pediatrics and the National Institutes of Health.
Data elements include demographics, circumstances of death, autopsy findings, toxicology, microbiology, histopathology, and genetic test results, with biospecimen repositories coordinated by accredited laboratories and biobanks at institutions like Broad Institute and Fred Hutchinson Cancer Research Center. Case submissions use secure electronic platforms with standardized data dictionaries and coding systems influenced by International Classification of Diseases frameworks and informatics guidance from National Library of Medicine. Analytical collaborations support bioinformatics pipelines for genomic interpretation developed in partnership with centers such as Broad Institute, Cold Spring Harbor Laboratory, and university core facilities.
Governance structures involve steering committees with representation from the Centers for Disease Control and Prevention, state health departments, medical examiner offices, and academic partners, guided by ethical frameworks consistent with institutional review boards at Johns Hopkins University and Harvard Medical School. Privacy protections include de-identification, data use agreements, and controlled-access procedures modeled on practices at the National Institutes of Health data repositories and biobank governance at institutions like UK Biobank. Engagement with stakeholder groups such as Families of SIDS Advocacy and clinical ethics boards ensures respect for bereaved families, with policy dialogues informed by regulatory frameworks like the Health Insurance Portability and Accountability Act where applicable.
Analyses from the registry have clarified contributions of cardiac channelopathies, structural cardiomyopathies, metabolic disorders, and undetected infections to unexplained deaths, informing clinical practice guidelines endorsed by American Heart Association and screening recommendations considered by pediatric and cardiology societies. Publications leveraging registry data have appeared in outlets such as The Lancet, Circulation, and Pediatrics, influencing family screening protocols at centers like Texas Children's Hospital, and prompting enhancements in medicolegal investigation practices advocated by the National Association of Medical Examiners. The registry’s integration of molecular autopsy findings has accelerated genotype-phenotype correlations and supported cascade testing initiatives undertaken by clinical genetics programs at institutions including Baylor College of Medicine and University of California, Los Angeles, thereby contributing to preventative cardiology and child health policy decisions.
Category:Public health surveillance